Valuation
- Market cap
- 266,000
- Revenue TTM
- $0
- Net income TTM
- $-1,150,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- -0.50
Trading
- Volume
- 2,000
- Avg volume
- 12,532
- Day's range
- $0.01 – $0.01
- Shares out
- 34,960,000
- Stochastic %K
- 42%
- Beta
- -1.82
- Analysts
- —
- Price target
- $1.00
Company profile
ChitogenX Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of orthopaedic and sports medicine surgeries in Canada. It develops Ortho-R, a biopolymer for rotator cuff repair; and Ortho-M, a biopolymer for meniscus repair. The company was formerly known as Ortho Regenerative Technologies I...
Show more
ChitogenX Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of orthopaedic and sports medicine surgeries in Canada. It develops Ortho-R, a biopolymer for rotator cuff repair; and Ortho-M, a biopolymer for meniscus repair. The company was formerly known as Ortho Regenerative Technologies Inc. and changed its name to ChitogenX Inc. in September 2022. ChitogenX Inc. was incorporated in 2015 and is headquartered in Kirkland, Canada.
- Industry
- Biotechnology
- Sector
- Healthcare
- Phone
- 514 261 4735
- Website
- https://www.chitogenx.com
- Address
- 16667 Hymus Boulevard, Kirkland, Canada
Latest news
No headlines yet.
